Daclatasvir Dihydrochloride
Daclatasvir Dihydrochloride (S5062-GRP)
Products
Description
Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S5062 |
| Target | HCV Protease |